First-Line Atezolizumab Plus Bevacizumab versus Sorafenib in Hepatocellular Carcinoma: A Cost-Effectiveness Analysis

Chiang, CL; Chan, SK; Lee, SF; Choi, HCW

Chiang, CL (corresponding author), Univ Hong Kong, Dept Clin Oncol, Hong Kong, Peoples R China.

CANCERS, 2021; 13 (5):

Abstract

Simple Summary There is a growing body of literature demonstrating high cancer drug costs relative to the benefits provided to patients treated on a l......

Full Text Link